Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts.

Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts.

scientific article

Author/s

Work details

Publication date: March 12, 2010

Language: English

Copyright status

Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.

To learn more about copyright terms in different countries, visit the countries and terms page.